S10 Ep9: FDA Approval Insights: Pirtobrutunib in Previously Treated CLL/SLL
Jan 25, 2024
10:54
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Davids discusses the FDA approval of pirtobrutinib for patients with previously treated CLL/SLL; key efficacy and safety data from the BRUIN trial; and guidelines for pirtobrutinib use in clinical practice in the CLL/SLL patient population.
OncLive® On Air